Backgroundand objectives DX5+CD4+ T cells have been shown to have both a protective- and therapeutic effect on collagen-induced arthritis. This protective effect was associated with an increase in IL-10 production. To understand the mechanisms used by DX5+ T cells to dampen Th1-associated inflammation in CIA, the authors recently studied their immunomodulatory action on CD4+ T cells. These studies revealed that these cells are very effective in modulating Th1-cell responses through direct effects on CD4+ T cells by production of IL-4. In the presence of DX5+ T cells, IFNγ production was inhibited whereas IL-10 secretion was induced in responding CD4+ T cells. To further define additional mechanisms applied by DX5+ T cells to inhibit Th1-immunity, the authors studied the effects of DX5+ T cells on DC function.
Materials and methods D011.10 (OVA specific TCR Tg) mice were used for the generation of bone marrow DCs (BMDCs) and for the isolation of CD4+ T cells.
BMDCs were cultured with DX5+ or DX5- supernatants for 3 days. LPS was added after 1 day of incubation. The DCs obtained were cultured at 0.4×106/ml with OVA323–339 peptide and OVA specific CD4+ T at 1×106/ml in total volume of 150 µl for 3 days. At day 3, the secretion of cytokines was determined by flow cytometry.
12p70 levels in BMDCs cell culture supernatants were measured by ELISA.
Results The authors demonstrate that DX5+ T cells can also indirectly inhibit Th1 responses through modulation of DC. DX5+ T cells robustly inhibit IL-12-production by DC. This effect was dependent on IL-10 produced by DX5+ T cells and does not require cell-cell contact. In addition, DX5+ T cells modulate the surface phenotype of LPS-matured DC as high levels of the “co-inhibitory” molecules PD-L1 and PD-L2 were induced. Importantly, OVA-specific CD4+ T cells primed by DC exposed to DX5+ T cell supernatant produced less IFNγ as compared to their counterparts primed by conventional DC. Addition of IL-12 restored IFNγ production. When IL-10 derived form DX5+ T cells was neutralised, DC re-established their ability to produce IL12 and to efficiently prime Th1 responses.
Conclusion These data show that DX5+ T cells cannot only directly inhibit Th1-cell immunity, but also indirectly through the modulation of DC.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.